SectorPharmaceutical
Established Date06/04/1998
Listing Date05/02/2021
ExchangeNASDAQ Stock Exchange
Full-time Employees33
Fiscal Year Ends31/12
Security TypeCommon stock
Office address451 D Street, 5th Floor, Boston, Massachusetts 02210
Business
IntroductionElicio Therapeutics Inc was incorporated in Delaware on April 6, 1998. The company is a clinical-stage biotechnology company developing a novel immunotherapy pipeline for the treatment of cancer and disease. By combining expertise in immunology and immunotherapy, Elicio is designing investigational amphiphilic (AMP) immunotherapies designed to precisely target and fully engage lymph nodes. Elicio is designing node-targeting amplifiers, immunomodulators, adjuvants and vaccines for a range of aggressive cancers and infectious diseases.
